We are live on ! Find out more
SIC

Salem Investment Counselors Portfolio holdings

AUM $4.03B
1-Year Est. Return 61.49%
This Fund
S&P 500
This Quarter Est. Return
-4.23%
1 Year Est. Return
+61.49%
3 Year Est. Return
+158.64%
5 Year Est. Return
+203.54%
10 Year Est. Return
+1,118.52%
AUM
$2.63B
AUM Growth
-$130M
Cap. Flow
+$6.64M
Cap. Flow %
0.25%
Top 10 Hldgs %
53.72%
Holding
1,201
New
50
Increased
190
Reduced
242
Closed
100

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$4.22M
2
GEHC icon
GE HealthCare
GEHC
+$3.88M
3
LLY icon
Eli Lilly
LLY
+$3.72M
4
NU icon
Nu Holdings
NU
+$2.87M
5
HSIC icon
Henry Schein
HSIC
+$2.67M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$8.53M
2
NVDA icon
NVIDIA
NVDA
+$8.34M
3
DIS icon
Walt Disney
DIS
+$3.82M
4
BWA icon
BorgWarner
BWA
+$3.26M
5
SWKS icon
Skyworks Solutions
SWKS
+$2.79M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 35.03%
2 Technology 20.98%
3 Healthcare 8.55%
4 Financials 8.13%
5 Communication Services 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SE icon
1051
Sea Limited
SE
$76.5B
$396 ﹤0.01%
9
– –
UNIT
1052
Uniti Group
UNIT
$2.33B
$388 ﹤0.01%
82
– –
SHYF
1053
DELISTED
The Shyft Group
SHYF
$375 ﹤0.01%
25
– –
BSET icon
1054
Bassett Furniture
BSET
$172M
$367 ﹤0.01%
25
-50
-67% -$782
IP icon
1055
International Paper
IP
$21.8B
$355 ﹤0.01%
10
– –
PXF icon
1056
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.98B
$349 ﹤0.01%
8
– –
QS icon
1057
QuantumScape Corp
QS
$3.81B
$348 ﹤0.01%
52
– –
GALT icon
1058
Galectin Therapeutics
GALT
$335M
$321 ﹤0.01%
167
– –
AA icon
1059
Alcoa
AA
$13.5B
$320 ﹤0.01%
11
– –
ARMP icon
1060
Armata Pharmaceuticals
ARMP
$169M
$300 ﹤0.01%
100
– –
RCL icon
1061
Royal Caribbean
RCL
$82.6B
$277 ﹤0.01%
+3
New +$301
TDC icon
1062
Teradata
TDC
$2.54B
$271 ﹤0.01%
6
– –
REZI icon
1063
Resideo Technologies
REZI
$3.24B
$269 ﹤0.01%
17
– –
NNOX icon
1064
Nano X Imaging
NNOX
$74.2M
$243 ﹤0.01%
37
– –
TR icon
1065
Tootsie Roll Industries
TR
$3.05B
$239 ﹤0.01%
9
– –
MAT icon
1066
Mattel
MAT
$4.23B
$221 ﹤0.01%
+10
New +$214
RIG icon
1067
Transocean
RIG
$6.42B
$214 ﹤0.01%
26
– –
ASIX icon
1068
AdvanSix
ASIX
$437M
$187 ﹤0.01%
6
– –
EMBC icon
1069
Embecta
EMBC
$291M
$181 ﹤0.01%
12
– –
FMAT icon
1070
Fidelity MSCI Materials Index ETF
FMAT
$612M
$177 ﹤0.01%
+4
New +$185
ZOM
1071
DELISTED
Zomedica Corp.
ZOM
$168 ﹤0.01%
1,000
– –
BH icon
1072
Biglari Holdings Class B
BH
$1.24B
$166 ﹤0.01%
1
– –
OPK icon
1073
Opko Health
OPK
$1.04B
$160 ﹤0.01%
100
– –
SPOT icon
1074
Spotify
SPOT
$102B
$155 ﹤0.01%
1
– –
ICOW icon
1075
Pacer Developed Markets International Cash Cows 100 ETF
ICOW
$1.84B
$150 ﹤0.01%
+5
New +$153
41 42
43
44 45

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return

Salem Investment Counselors's Q3 2023 Portfolio in Review

As of Q3 2023, Salem Investment Counselors held 1,201 positions worth $2.63B, down 4.7% from $2.75B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Salem Investment Counselors's Q3 2023 filing shows 50 new, 190 increased, 242 reduced and 100 closed positions. Its largest new stake was Blue Owl Capital: 137,355 shares worth $1.95M. The largest sale was Pfizer, an estimated $8.53M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.

  • Salem Investment Counselors's largest Q3 2023 buy was Blue Owl Capital: 137,355 shares worth $1.95M.
  • Salem Investment Counselors added most to Amgen in Q3 2023, an estimated $4.22M increase.
  • Salem Investment Counselors's biggest Q3 2023 reduction was Pfizer, cutting an estimated $8.53M.
  • Salem Investment Counselors fully exited BorgWarner in Q3 2023, selling an estimated $3.26M.
  • Salem Investment Counselors's ten largest holdings make up 54% of its $2.63B portfolio in Q3 2023.
  • Salem Investment Counselors opened 50 new positions and closed 100 in Q3 2023.
  • Salem Investment Counselors's portfolio value fell 4.7% quarter-over-quarter to $2.63B.

Based on Salem Investment Counselors's 13F filing for Q3 2023, filed 4 Oct 2023.